Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2016 | $608,743 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | Pennsylvania | state | 2016 | $237,427 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2016 | $671,544 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $621,710 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $118,253 | | tax credit/rebate |
Shire ViroPharma, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2016 | $85,794 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2016 | $269,391 | | tax credit/rebate |
Janssen Research & Development, LLC | Johnson & Johnson | Pennsylvania | state | 2017 | $4,768,953 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | 2017 | $1,494,073 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2017 | $1,113,133 | | tax credit/rebate |
Spark Therapeutics, LLC | Roche | Pennsylvania | state | 2017 | $790,740 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. | AbbVie | Pennsylvania | state | 2017 | $726,780 | | tax credit/rebate |
Janssen Biotech, Inc. | Johnson & Johnson | Pennsylvania | state | 2017 | $720,954 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Pennsylvania | state | 2017 | $693,503 | | tax credit/rebate |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2017 | $506,455 | | tax credit/rebate |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | Pennsylvania | state | 2017 | $160,094 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2017 | $137,235 | | tax credit/rebate |
Aclaris Therapeutics, Inc. | Aclaris Therapeutics | Pennsylvania | state | 2017 | $93,554 | | tax credit/rebate |
Jazz Pharmaceuticals, Inc. | Jazz Pharmaceuticals | Pennsylvania | state | 2017 | $83,373 | | tax credit/rebate |
Liquent, Inc. | Parexel International | Pennsylvania | state | 2017 | $65,812 | | tax credit/rebate |
NewLink Genetics Corporation | Lumos Pharma | Pennsylvania | state | 2017 | $26,749 | | tax credit/rebate |
Astellas Pharma Global Development, Inc. | Astellas Pharma | Pennsylvania | state | 2017 | $19,037 | | tax credit/rebate |
Janssen Research & Development, LLC | Johnson & Johnson | Pennsylvania | state | 2018 | $10,025 | | tax credit/rebate |
JANSSEN RESEARCH & DEVELOPMENT LLC | Johnson & Johnson | Pennsylvania | state | 2019 | $6,841 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Pennsylvania | state | 2018 | $1,157 | | tax credit/rebate |
Spark Therapeutics, Inc. | Roche | Pennsylvania | state | 2019 | $2,000,000 | | grant |
AVID RADIOPHARMACEUTICALS INC | Eli Lilly | Pennsylvania | state | 2020 | $9,000 | | tax credit/rebate |
EISAI INC | Eisai | Pennsylvania | state | 2020 | $106,100 | | tax credit/rebate |
ELI LILLY & COMPANY | Eli Lilly | Pennsylvania | state | 2020 | $96,100 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Pennsylvania | state | 2020 | $212,300 | | tax credit/rebate |
GLAXOSMITHKLINE LLC | GlaxoSmithKline | Pennsylvania | state | 2020 | $3,388,900 | | tax credit/rebate |
JANSSEN BIOTECH INC | Johnson & Johnson | Pennsylvania | state | 2020 | $644,100 | | tax credit/rebate |
JANSSEN RESEARCH & DEVELOPMENT LLC | Johnson & Johnson | Pennsylvania | state | 2020 | $6,332,600 | | tax credit/rebate |
JAZZ PHARMACEUTICALS INC | Jazz Pharmaceuticals | Pennsylvania | state | 2020 | $115,000 | | tax credit/rebate |
MERCK SHARP & DOHME CORP | Merck | Pennsylvania | state | 2020 | $1,759,300 | | tax credit/rebate |
SHIRE HUMAN GENETIC THERAPIES INC | Takeda Pharmaceutical | Pennsylvania | state | 2020 | $121,300 | | tax credit/rebate |
SPARK THERAPEUTICS, LLC | Roche | Pennsylvania | state | 2020 | $1,687,300 | | tax credit/rebate |
ULTRAGENYX PHARMACEUTICAL INC | Ultragenyx Pharmaceutical | Pennsylvania | state | 2020 | $34,700 | | tax credit/rebate |
VENTANA USA | Roche | Pennsylvania | state | 2020 | $4,200 | | tax credit/rebate |
VERSUM MATERIALS INC | Merck KGaA (EMD) | Pennsylvania | state | 2020 | $16,500 | | tax credit/rebate |
Janssen Research & Development LLC | Johnson & Johnson | Pennsylvania | state | 2021 | $7,844,600 | | tax credit/rebate |
Janssen Biotech Inc | Johnson & Johnson | Pennsylvania | state | 2021 | $1,148,700 | | tax credit/rebate |
Eli Lilly & Company | Eli Lilly | Pennsylvania | state | 2021 | $303,000 | | tax credit/rebate |
Shire Human Genetic Therapies Inc | Takeda Pharmaceutical | Pennsylvania | state | 2021 | $294,400 | | tax credit/rebate |
Eisai Inc | Eisai | Pennsylvania | state | 2021 | $228,700 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Pennsylvania | state | 2021 | $83,700 | | tax credit/rebate |
Jazz Pharmaceuticals Inc | Jazz Pharmaceuticals | Pennsylvania | state | 2021 | $80,200 | | tax credit/rebate |
Ultragenyx Pharmaceutical Inc | Ultragenyx Pharmaceutical | Pennsylvania | state | 2021 | $53,100 | | tax credit/rebate |
Avid Radiopharmaceuticals Inc | Eli Lilly | Pennsylvania | state | 2021 | $28,300 | | tax credit/rebate |
Novo Nordisk Inc. | Novo Holdings A/S | Pennsylvania | state | 2021 | $27,100 | | tax credit/rebate |
Glaxosmithkline Consumer Healthcare Hold | GlaxoSmithKline | Pennsylvania | state | 2021 | $15,900 | | tax credit/rebate |
Advanced Neuromodulation Systems, Inc. | Abbott Laboratories | Oregon | state | 2006 | $29,872 | | training reimbursement |
Genentech USA Inc. | Roche | Oregon | state | 2012 | $3,817,197 | | property tax abatement |
Genentech Inc | Roche | Oregon | state | 2013 | $3,340,842 | | tax credit/rebate |
Genentech | Roche | Oregon | state | 2013 | $227,332 | | property tax abatement |
Genentech USA, Inc | Roche | Oregon | state | 2019 | $500,260 | | grant |
Genentech USA, Inc | Roche | Oregon | state | 2020 | $1,573,000 | | grant |
Genentech Inc | Roche | Oregon | local | 2023 | $3,134,511 | | property tax abatement |
BEN VENUE LABORATORIES | Boehringer Ingelheim | Ohio | state | 2001 | $2,439,160 | | enterprise zone |
BEN VENUE LABORATORIES, INC. | Boehringer Ingelheim | Ohio | state | 2005 | $2,246,703 | | enterprise zone |
BEN VENUE LABORATORIES, INC. | Boehringer Ingelheim | Ohio | state | 2006 | undisclosed | | enterprise zone |
BEN VENUE LABORATORIES | Boehringer Ingelheim | Ohio | state | 2007 | undisclosed | | enterprise zone |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2008 | undisclosed | | enterprise zone |
Andrx/Anda Pharmaceuticals (Lexington Groveport I LLC & Anda Pharm) | Teva Pharmaceutical Industries | Ohio | local | 2009 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #2) | Hikma Pharmaceuticals | Ohio | local | 2009 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #3) | Hikma Pharmaceuticals | Ohio | local | 2009 | undisclosed | | property tax abatement |
Andrx/Anda Pharmaceuticals (Lexington Groveport I LLC & Anda Pharm) | Teva Pharmaceutical Industries | Ohio | local | 2010 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #2) | Hikma Pharmaceuticals | Ohio | local | 2010 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #3) | Hikma Pharmaceuticals | Ohio | local | 2010 | undisclosed | | property tax abatement |
Andrx/Anda Pharmaceuticals | Teva Pharmaceutical Industries | Ohio | local | 2011 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #2) | Hikma Pharmaceuticals | Ohio | local | 2011 | undisclosed | | property tax abatement |
Boehringer Ingelheim Roxane, Inc. and Affiliates (Roxane #3) | Hikma Pharmaceuticals | Ohio | local | 2011 | undisclosed | | property tax abatement |
Amylin Pharmaceuticals | AstraZeneca | Ohio | multiple | 2007 | $117,000,000 | | MEGADEAL |
PHARMAFORCE INC | Daiichi Sankyo | Ohio | state | 2009 | $250,000 | | grant |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $695,000 | | grant |
PHARMAFORCE INC | Daiichi Sankyo | Ohio | state | 2009 | | $6,000,000 | loan or bond financing |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | | $1,500,000 | loan or bond financing |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2008 | $47,957 | | grant |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2008 | $20,000 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2009 | $414,661 | | grant |
BEN VENUE LABORATORIES INC | Boehringer Ingelheim | Ohio | state | 2009 | $45,000 | | grant |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $300,000 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2012 | $45,000 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2010 | $31,792 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2010 | $138,219 | | grant |
BOEHRINGER INGLEHEIM | Boehringer Ingelheim | Ohio | state | 2011 | $55,000 | | grant |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2012 | $1,380,000 | | grant |
BOEHRINGER INGLEHEIM | Boehringer Ingelheim | Ohio | state | 2012 | $195,000 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2013 | $150,000 | | grant |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2008 | $879,466 | | tax credit/rebate |
PBM Covington, LLC | Perrigo | Ohio | state | 2009 | $339,354 | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Ohio | state | 2012 | $5,369,069 | | tax credit/rebate |
Boehringer Ingelheim Roxane, Inc./Roxane Laboratories, Inc. | Hikma Pharmaceuticals | Ohio | state | 2012 | undisclosed | | enterprise zone |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2013 | $25,390 | | training reimbursement |
Roxane Laboratories, Inc. et al. | Hikma Pharmaceuticals | Ohio | state | 1994 | undisclosed | | tax credit/rebate |
Ben Venue Laboratories, Inc. | Boehringer Ingelheim | Ohio | state | 1999 | undisclosed | | tax credit/rebate |
Anda Pharmaceuticals, Inc. | AbbVie | Ohio | state | 2001 | undisclosed | | tax credit/rebate |
Roxane Laboratories, Inc. et al. | Hikma Pharmaceuticals | Ohio | state | 2002 | undisclosed | | tax credit/rebate |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2004 | undisclosed | | tax credit/rebate |
Abbott Laboratories, Ross Products Division | Abbott Laboratories | Ohio | state | 2006 | undisclosed | | tax credit/rebate |
APTALIS PHARMATECH INC | AbbVie | Ohio | state | 2014 | $159,943 | | grant |